Guideline for management of vasculitis syndrome (JCS 2008). Japanese Circulation Society.
D000328:Adult; D002317:Cardiovascular Agents / Q000627:therapeutic use; D005260:Female; D013700:Giant Cell Arteritis / Q000175:diagnosis / Q000209:etiology / Q000473:pathology / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D010488:Polyarteritis Nodosa / Q000175:diagnosis / Q000209:etiology / Q000473:pathology / Q000628:therapy; D013577:Syndrome; D056647:Systemic Vasculitis / Q000175:diagnosis / Q000209:etiology / Q000473:pathology / Q000628:therapy; D013625:Takayasu Arteritis / Q000175:diagnosis / Q000209:etiology / Q000473:pathology / Q000628:therapy; D013919:Thromboangiitis Obliterans / Q000175:diagnosis / Q000209:etiology / Q000473:pathology / Q000628:therapy; D014657:Vasculitis / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000473:pathology / Q000628:therapy*
D002317:Cardiovascular Agents; D007166:Immunosuppressive Agents